96334000: Prednisolone acetate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\Glucocorticoid (substance)\Prednisolone acetate
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Prednisolone acetate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Prednisolone acetate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Prednisolone acetate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Prednisolone acetate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Steroid hormone\Glucocorticoid (substance)\Prednisolone acetate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid (substance)\...

\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Prednisolone acetate

\Pregnane (substance)\Prednisolone acetate

\Steroid hormone\Glucocorticoid (substance)\Prednisolone acetate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

159452010 Prednisolone acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

840676015 Prednisolone acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2656451000005119 Prednisolonacetat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Prednisolone acetate	Is a	Acetate	false	Inferred relationship	Some
Prednisolone acetate	Is a	Product containing prednisolone (medicinal product)	false	Inferred relationship	Some
Prednisolone acetate	Is a	Prednisolone	false	Inferred relationship	Some
Prednisolone acetate	Is a	syntetisk glucocorticoid	false	Inferred relationship	Some
Prednisolone acetate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Prednisolone	true	Inferred relationship	Some
Prednisolone acetate	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Prednisolone acetate	Is a	Pregnane (substance)	true	Inferred relationship	Some
Prednisolone acetate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Prednisolone acetate	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Prednisolone acetate	Is a	Glucocorticoid (substance)	true	Inferred relationship	Some
Prednisolone acetate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Prednisolone acetate [musculoskeletal use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 25 mg/ml injektionsvæske, suspension, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate 50mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 25 mg/ml suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate 50mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 50 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 25 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate 1.25 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate 10 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate 1%	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
gentamicinsulfat 0,3 % wt/wt + prednisolonacetat 0,6 % wt/wt salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
gentamicinsulfat + prednisolonacetat 0,3 %/1 % vol/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
neomycinsulfat + polymyxin B-sulfat + prednisolonacetat 0,35 %/10.000 enheder/0,5 % wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat + sulfacetamidnatrium 0,2 % wt/vol/10 % wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 5 mg + sulfacetamidnatrium 100 mg salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 5 mg + sulfacetamidnatrium 100 mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
neomycinsulfat + polymyxin B-sulfat + prednisolonacetat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
gentamicinsulfat + prednisolonacetat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat + sulfacetamidnatrium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 0,5 % wt/wt + sulfacetamidnatrium 10 % wt/wt salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonnatriumphosphat 2,5 mg + sulfacetamidnatrium 100 mg opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Prednisolone 3 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
prednisolonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 30 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prednisolone acetate	Inferred relationship	Some
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Prednisolone acetate	Inferred relationship	Some	1
Prednisolone acetate 25 mg/mL suspension for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	1
Prednisolone acetate 25 mg/mL suspension for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	1
Prednisolone acetate 1.25 mg/mL eye suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	1
Prednisolone acetate 1.25 mg/mL eye suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	1
Prednisolone acetate 10 mg/mL eye suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	1
Prednisolone acetate 10 mg/mL eye suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	1
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	2
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	2
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	2
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	2
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	1
Product containing precisely prednisolone (as prednisolone acetate) 5 milligram/1 gram conventional release oromucosal paste (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prednisolone acetate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
159452010	Prednisolone acetate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
840676015	Prednisolone acetate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2656451000005119	Prednisolonacetat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)